• LAST PRICE
    8.6989
  • TODAY'S CHANGE (%)
    Trending Down-0.5989 (-6.4413%)
  • Bid / Lots
    8.9000/ 8
  • Ask / Lots
    9.2500/ 1
  • Open / Previous Close
    9.2500 / 9.2978
  • Day Range
    Low 8.5201
    High 9.2500
  • 52 Week Range
    Low 7.3500
    High 21.6700
  • Volume
    1,966
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 9.2978
TimeVolumeMDBH
09:32 ET1469.25
09:36 ET1809.05
10:01 ET1008.65
10:21 ET4008.5201
10:37 ET8008.6989
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMDBH
MDB Capital Holdings LLC
86.4M
-11.9x
---
United StatesWAYS
New York Holding Corp
86.5M
-30.1x
---
United StatesNXC
Nuveen California Select Tax-Free Income Portfolio
83.6M
0.0x
---
United StatesTOP
TOP Financial Group Ltd
95.1M
16.9x
---
United StatesELRNF
Elron Ventures Ltd
73.6M
-7.8x
---
United StatesMFH
Mercurity Fintech Holding Inc
79.1M
-7.0x
---
As of 2024-05-02

Company Information

MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, Invizyne Technologies, Inc. (Invizyne). The Company's segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment has one subsidiary, Invizyne. Invizyne is a research and development stage synthetic biology company. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.

Contact Information

Headquarters
4209 Meadowdale LnDALLAS, TX, United States 95229
Phone
310-526-5000
Fax
302-636-5454

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$86.4M
Revenue (TTM)
$6.0M
Shares Outstanding
9.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.73
Book Value
$4.01
P/E Ratio
-11.9x
Price/Sales (TTM)
14.3
Price/Cash Flow (TTM)
---
Operating Margin
-140.66%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.